RxDoctor Payments Data

Dustin Pine

Medical · Mc Connellsburg, PANPI 1619381597

Payments from drug & device makers

$2,543in general payments, 2019–2025

Across 132 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$404
  • Novartis$322
  • Daiichi Sankyo Inc.$224
  • Johnson & Johnson$215
  • E.r. Squibb & Sons, L.L.C.$214
  • Boehringer Ingelheim$194
  • plus $970 from 17 others

What the payments were for

  • Food & beverage$2,543100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,543 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban295$227,628
MultaqDronedarone Hcl59$60,595
JardianceEmpagliflozin78$50,547
XareltoRivaroxaban30$24,644
EntrestoSacubitril/Valsartan15$12,015
Repatha SureclickEvolocumab12$11,383
Metoprolol Succinate301$3,107
Amiodarone Hcl90$2,617
Dofetilide43$2,375
Rosuvastatin Calcium275$2,109
Atorvastatin Calcium144$1,860
Isosorbide Mononitrate ErIsosorbide Mononitrate150$1,713
Bumetanide57$1,709
Ezetimibe62$1,619
Losartan Potassium122$1,552

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$404$227,628295 claims
Sanofi-aventis U.S. LLCMultaq$66$60,59559 claims
Boehringer IngelheimJardiance$194$50,54778 claims
Johnson & JohnsonXarelto$215$24,64430 claims
NovartisEntresto$322$12,01515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Mc Connellsburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →